193 related articles for article (PubMed ID: 14583781)
1. c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.
Arango D; Mariadason JM; Wilson AJ; Yang W; Corner GA; Nicholas C; Aranes MJ; Augenlicht LH
Br J Cancer; 2003 Nov; 89(9):1757-65. PubMed ID: 14583781
[TBL] [Abstract][Full Text] [Related]
2. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
Wu Q; Kirschmeier P; Hockenberry T; Yang TY; Brassard DL; Wang L; McClanahan T; Black S; Rizzi G; Musco ML; Mirza A; Liu S
J Biol Chem; 2002 Sep; 277(39):36329-37. PubMed ID: 12138103
[TBL] [Abstract][Full Text] [Related]
4. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
5. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
[TBL] [Abstract][Full Text] [Related]
6. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
Han Z; Wei W; Dunaway S; Darnowski JW; Calabresi P; Sedivy J; Hendrickson EA; Balan KV; Pantazis P; Wyche JH
J Biol Chem; 2002 May; 277(19):17154-60. PubMed ID: 11877436
[TBL] [Abstract][Full Text] [Related]
7. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
9. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
Bukholm IK; Nesland JM
Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
[TBL] [Abstract][Full Text] [Related]
10. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.
Jeong JH; Kang SS; Park KK; Chang HW; Magae J; Chang YC
Mol Cancer Ther; 2010 Jul; 9(7):2102-13. PubMed ID: 20587660
[TBL] [Abstract][Full Text] [Related]
11. p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells.
Perletti G; Marras E; Dondi D; Osti D; Congiu T; Ferrarese R; de Eguileor M; Tashjian AH
Int J Cancer; 2005 Jan; 113(1):42-53. PubMed ID: 15386430
[TBL] [Abstract][Full Text] [Related]
12. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
[TBL] [Abstract][Full Text] [Related]
13. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
Akimoto T; Seong J; Hunter NR; Buchmiller L; Mason K; Milas L
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):413-9. PubMed ID: 10760438
[TBL] [Abstract][Full Text] [Related]
14. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
15. The interactive transcript abundance index [c-myc*p73alpha]/[p21*Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines.
Harr MW; Willey JC
Int J Oncol; 2007 Jun; 30(6):1553-60. PubMed ID: 17487378
[TBL] [Abstract][Full Text] [Related]
16. c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.
Mukherjee S; Conrad SE
J Biol Chem; 2005 May; 280(18):17617-25. PubMed ID: 15757889
[TBL] [Abstract][Full Text] [Related]
17. MT1G Regulates c-MYC/P53 Signal to Inhibit Proliferation, Invasion and Migration and Promote Apoptosis in Colon Cancer Cells.
Li J; Hu Q; Li Z; Feng K; Li K
Curr Mol Med; 2024; 24(3):379-388. PubMed ID: 36999424
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent apoptosis in melanoma cells after treatment with camptothecin.
Li G; Bush JA; Ho VC
J Invest Dermatol; 2000 Mar; 114(3):514-9. PubMed ID: 10692111
[TBL] [Abstract][Full Text] [Related]
19. Suppression of c-Myc enhances p21
Jeong YJ; Hoe HS; Cho HJ; Park KK; Kim DD; Kim CH; Magae J; Kang DW; Lee SR; Chang YC
J Cell Biochem; 2018 Feb; 119(2):2036-2047. PubMed ID: 28833404
[TBL] [Abstract][Full Text] [Related]
20. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.
Iyengar RV; Pawlik CA; Krull EJ; Phelps DA; Burger RA; Harris LC; Potter PM; Danks MK
Cancer Res; 2001 Apr; 61(7):3045-52. PubMed ID: 11306486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
